Corporate information

Registration country

Company type

Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs.

Overview

Maridose in collaboration with Israel’s medical marijuana pioneer Tikun-Olam has been approved by the US Drug Enforcement Administration (DEA) to be a Schedule 1 drug manufacturer licensed to cultivate marijuana for research and commercial product development purposes. Our research/cultivation facility and Center of Excellence for Cannabis Research is located at Brunswick Landing in Brunswick, Maine. Unlike the approximately 600 Schedule 1 cannabis “researchers”, our license allows us to legally research the live plant.



Funding rounds

Pre Seed USD 150,000


USD 150,000 ( )



Investment activity status
Active investor

Current team

Current team

Financials